
    
      -  Type of study/ Design: Randomized, double-blind, placebo-controlled clinical trial.

        -  Sponsor: Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol /
           Hospital Universitari Germans Trias i Pujol ( IGTP / HUGTIP)

        -  Title of the clinical trial: Efficacy of micronutrient dietary supplementation in
           reducing hospital admissions for COVID-19: A double-blind, placebo-controlled,
           randomized clinical trial.

        -  Protocol code: CoVIT Clinical Trial

        -  NºClinicaltrials.gov: Pending

        -  Coordinating researcher: Dra. Teresa-Maria Tomasa-Irriguible.

        -  Recruiting Center: Germans Trias i Pujol University Hospital (HUGTIP)

        -  Ethical Committee for clinical Investigation (CEI): Germans Trias i Pujol University
           Hospital CEI.

        -  Monitoring: Clinical Research Associate at UPIC (Unitat Polivalent d'Investigació
           Clínica) Clinical Trial Unit- IGTP

        -  Study treatments: Dietary supplement with micronutrients and Placebo

        -  Test phase: Not applicable.

        -  Main objective: Evaluation of the effectiveness of supplementation with a dietary
           supplement to improve the need for hospital admission for SARS-CoV-2 infection.

        -  Study pathology: COVID-19.

        -  Main variable: The need for hospital admission of SARS-CoV-2 documented infection

        -  Study population and total number of patients: Patients of the health system of the
           Northern Metropolitan Area of Catalan Health Institution with symptoms compatible with
           SARS-CoV-2 infection. A total of 300 people (150 treated with dietary supplement and 150
           with placebo).

        -  Duration of treatment: 14 days.

        -  Patients follow-up: 90 days
    
  